NHIA is currently requesting its members to take action regarding the Medicare Part B home infusion reimbursement issue regarding CMS’ July 2, 2018 proposed rule.
We need Congress to pass legislation that will improve the quality of senior patient care and reduce health care spending by allowing Medicare beneficiaries that need infused drug therapies to receive treatment in their homes.
Every stakeholder is critical to ensuring Congress and the Administration understand home infusion and how they can support the home infusion industry. Our ultimate legislative and regulatory success will require a grassroots presence in every state and congressional district across the country. The home infusion industry needs you to be active and engaged! NHIA is urging you take action in support of home infusion.
Join NHIA in urging Congress to act.
Learn more about Medicare Part D reimbursementClick here